[AGTR1 A1166C polymorphism is associated with risk of diabetic nephropathy]

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2013 Jan;42(1):45-51. doi: 10.3785/j.issn.1008-9292.2013.01.008.
[Article in Chinese]

Abstract

Objective: To investigate whether the angiotensin II type I receptor gene (AGTR1) A1166C polymorphism is associated with a high risk of diabetic nephropathy.

Methods: The allele frequency and the genotype distribution of the AGTR1 A1166C polymorphism were studied in normal controls (157 cases), simple diabetes (141 cases, duration of diabetes >10 years), and diabetic nephropathy (152 cases) by means of polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).

Results: Patients with diabetic nephropathy had a higher frequency of C allele of the AGTR1 A1166C polymorphism than that of normal controls and simple diabetes (P<0.05); but there was no significant difference in frequency of C allele between the normal controls and patients with simple diabetes.

Conclusion: The diabetic patients with AGTR1 C allele may be more susceptible to diabetic nephropathy than diabetic patients with A allele.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Diabetic Nephropathies / genetics*
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Genetic*
  • Receptor, Angiotensin, Type 1 / genetics*

Substances

  • AGTR1 protein, human
  • Receptor, Angiotensin, Type 1